…
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Green Thumb Industries is a U.S. multi-state cannabis company that manufactures branded cannabis products and operates consumer dispensaries under the Rise retail banner. Long-term growth may be supported by expanding retail footprint, scaling branded product sales and broader state-level legalization that could increase market access. Investors may find the company attractive because it appears positioned among larger MSOs with vertically integrated operations and diversified state exposure.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 263.36M | 200.14M | 156.05M | 108.43M | 204.97M |
| Minority interest | -1.90M | -0.77M | -1.15M | -1.68M | -4.93M |
| Net income | 114.15M | 73.08M | 36.27M | 11.98M | 75.44M |
| Selling general administrative | 437.19M | 376.23M | 336.40M | 292.98M | 272.34M |
| Gross profit | 574.89M | 601.11M | 526.50M | 503.96M | 491.93M |
| Reconciled depreciation | 197.01M | 167.59M | 149.02M | 140.65M | 102.58M |
| Ebit | - | - | - | 210.99M | 221.62M |
| Ebitda | - | - | - | 129.63M | 329.53M |
| Operating income | 137.70M | 224.43M | 185.91M | 121.06M | 204.20M |
| Interest expense | 20.02M | 24.27M | 19.07M | 21.20M | 21.98M |
| Tax provision | 147.30M | 126.29M | 118.63M | 94.78M | 124.61M |
| Interest income | 11.38M | 27.07M | 30.01M | 13.35M | 1.79M |
| Net interest income | -8.64M | -15.19M | -12.38M | -17.13M | -20.54M |
| Income tax expense | - | - | - | 94.78M | 124.61M |
| Total revenue | 1175.30M | 1137.14M | 1054.55M | 1017.38M | 893.56M |
| Total operating expenses | 1037.60M | 912.72M | 869.92M | 807.81M | 678.72M |
| Cost of revenue | 600.40M | 536.03M | 528.06M | 513.41M | 401.63M |
| Total other income expense net | 134.30M | -9.09M | -16.21M | -84.00M | 10.68M |
| Net income from continuing ops | 116.05M | 73.85M | 37.42M | 13.65M | 80.36M |
| Net income applicable to common shares | - | 73.08M | 36.27M | 11.98M | 75.44M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 2790.06M | 2537.01M | 2490.06M | 2433.53M | 2385.85M |
| Intangible assets | 436.68M | 488.29M | 538.68M | 589.52M | 675.49M |
| Other current assets | 18.40M | 14.68M | 5.38M | 6.18M | 5.07M |
| Total liab | 879.41M | 747.93M | 786.80M | 768.61M | 764.74M |
| Total stockholder equity | 1905.43M | 1789.28M | 1702.88M | 1664.92M | 1621.12M |
| Other current liab | - | - | - | 15.76M | 83.54M |
| Common stock | - | 1758.50M | 1703.85M | 1663.56M | 1633.67M |
| Capital stock | 1780.59M | 1758.50M | 1703.85M | 1663.56M | 1633.67M |
| Retained earnings | 165.42M | 51.27M | -21.82M | -58.09M | -70.06M |
| Other liab | - | - | - | 97.61M | 140.30M |
| Good will | 592.15M | 589.69M | 589.69M | 589.69M | 632.85M |
| Other assets | - | 4.69M | 3.60M | 3.06M | 2.64M |
| Cash | 274.30M | 171.69M | 161.63M | 177.68M | 230.42M |
| Cash and equivalents | - | 171.69M | 161.63M | 177.68M | 230.42M |
| Total current liabilities | 177.31M | 164.97M | 126.05M | 146.57M | 204.38M |
| Net debt | - | 83.27M | 146.89M | 96.95M | 9.51M |
| Short term debt | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Short long term debt | 18.50M | 12.06M | 3.00M | 1.04M | 0.78M |
| Other stockholder equity | - | - | - | 36.21M | 36.26M |
| Property plant equipment | - | 962.29M | 925.48M | 800.23M | 585.40M |
| Total current assets | 577.17M | 403.90M | 342.76M | 351.35M | 364.23M |
| Long term investments | 205.88M | 83.88M | 89.30M | 99.68M | 125.24M |
| Net tangible assets | - | - | - | 485.71M | 312.78M |
| Net receivables | 51.27M | 52.83M | 42.98M | 30.98M | 22.10M |
| Long term debt | 226.40M | 242.90M | 305.53M | 274.63M | 239.15M |
| Inventory | 158.29M | 147.16M | 112.97M | 115.67M | 95.47M |
| Accounts payable | 24.57M | 24.77M | 24.50M | 18.42M | 14.09M |
| Non currrent assets other | 2.10M | 2.17M | 2.56M | 102.74M | 127.88M |
| Non current assets total | 2212.89M | 2133.11M | 2147.30M | 2082.18M | 2021.62M |
| Capital lease obligations | 273.45M | 275.74M | 261.76M | 249.28M | 191.76M |
| Long term debt total | - | 242.90M | 305.53M | 274.63M | 239.15M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -75.49M | -89.54M | -227.91M | -2.23M | -60.63M |
| Change to liabilities | - | - | - | 3.57M | -9.53M |
| Total cashflows from investing activities | - | -89.54M | -227.91M | -219.95M | -280.73M |
| Net borrowings | -10.70M | -56.64M | 24.42M | 19.15M | 138.19M |
| Total cash from financing activities | -50.94M | -95.59M | -13.11M | 8.64M | 295.34M |
| Change to operating activities | - | - | - | -39.54M | -24.04M |
| Net income | 114.15M | 73.08M | 36.27M | 11.98M | 75.44M |
| Change in cash | 113.59M | 10.05M | -16.05M | -52.74M | 146.66M |
| Begin period cash flow | 171.69M | 161.63M | 177.68M | 230.42M | 83.76M |
| End period cash flow | 285.28M | 171.69M | 161.63M | 177.68M | 230.42M |
| Total cash from operating activities | 294.93M | 195.18M | 224.97M | 158.56M | 132.05M |
| Issuance of capital stock | - | - | 0.00M | 0.00M | 155.50M |
| Depreciation | 197.01M | 167.59M | 100.79M | 140.65M | 102.58M |
| Other cashflows from investing activities | - | -9.35M | -7.87M | -40.45M | -92.88M |
| Dividends paid | - | - | - | - | 11.03M |
| Change to inventory | -12.89M | -34.19M | 2.62M | -19.79M | -16.44M |
| Change to account receivables | 1.09M | -9.86M | -12.00M | -9.26M | -0.65M |
| Sale purchase of stock | -38.87M | -31.78M | -36.23M | 3.82M | 171.43M |
| Other cashflows from financing activities | - | -7.18M | -1.29M | -14.33M | -14.28M |
| Change to netincome | - | - | - | 67.03M | 12.06M |
| Capital expenditures | 81.07M | 80.19M | 220.03M | 179.50M | 187.85M |
| Change in working capital | -75.93M | -82.64M | -34.34M | -70.27M | -65.27M |
| Stock based compensation | 44.93M | 33.31M | 28.19M | 27.14M | 19.60M |
| Other non cash items | -5.74M | -12.55M | 13.60M | -21.42M | 6.10M |
| Free cash flow | 213.86M | 115.00M | 4.93M | -20.94M | -55.80M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| GTII Green Thumb Industries Inc |
-0.29 3.18% |
8.84 | 14.70 | 34.84 | 1.91 | 0.86 | 1.61 | 3.95 |
| CL Cresco Labs Inc |
-0.02 2.41% |
0.81 | - | 105.26 | 0.70 | 0.99 | 1.32 | 42.44 |
| JUSH Jushi Holdings Inc |
-0.02 3.03% |
0.64 | - | 17.86 | 0.52 | 0.69 | 1.41 | 9.56 |
| GRIN Grown Rogue International Inc |
- -% |
0.51 | 23.50 | - | 3.62 | 4.10 | 3.13 | 11.19 |
| AAWH-U Ascend Wellness Holdings Inc. |
-0.01 2.56% |
0.38 | - | 10.88 | 0.22 | 59.95 | 1.23 | 7.98 |
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
| Name | Title | Year Born |
|---|---|---|
| Mr. Benjamin Kovler | Founder, Chairman & CEO | 1979 |
| Mr. Anthony Georgiadis | President & Director | 1978 |
| Mr. Mathew Faulkner | Chief Financial Officer | 1974 |
| Mr. Bret Kravitz | General Counsel & Secretary | 1980 |
| Mr. Matt Navarro | President of Operations | NA |
| Mr. Josh Barrington | Senior Vice President of Technology | NA |
| Ms. Rachel Albert | Chief Administrative Officer | NA |
| Mr. Andrew Laurence Grossman | EVP of Capital Markets & Investor Relations | 1975 |
| Ms. Tracy Brady | Senior Vice President of Communications | NA |
| Ms. Kelly Dean | Senior Vice President of People | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.